/Investor DB

Versant Venture AIV Holdings

Venture capital

San Francisco · 6 people tracked

Find your way into Versant Venture AIV Holdings

Each arrow is one introduction. Sign up to fill in the first one.

752 people can intro you to Kirk

Ask Justin Klein to introduce you to Kirk Nielsen

You →Justin · together at Vensana Capital →Kirk

300 people can intro you to Robin

Ask Jamie Chen to introduce you to Robin Praeger

You →Jamie · together at Arthur Young →Robin

75 people can intro you to Sam

Ask Sam Okafor to introduce you to Sam Colella

You →Sam · together at Versant Ventures →Sam

Sign up to find every way you can get introduced to Versant Venture AIV Holdings

  • Your email: who you already know at Versant Venture AIV Holdings, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Versant Venture AIV Holdings team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Fund manager profile

Versant Venture AIV Holdings is a venture fund manager based in San Francisco. SEC filings show 2 venture funds on record, most recently Versant Venture V AIV Feeder Holdings, L.P. ($5.3M offering) filed November 2016.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
San Francisco, US
Founded
2016
Tracked investments
14
IPOs
4

Team · 6 people

from public directories
Bradley Bolzon· General Partner
Sam Colella· General Partnerin
Thomas Woiwode· General Partner

What they invest in

from 13 of 14 portfolio companies

Healthtech ×9Biotech ×7Medical Devices ×4Deep Tech ×1

HQs:United States×14

Investments · 14 tracked

founders shown can be your intro path

By year:2023 · 12019 · 22018 · 12017 · 62016 · 32015 · 114 dated

Edwards Lifesciencesedwards.comin𝕏NYSE: EWJan 2017SEC filingmedium confidence

Edwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions.

BiotechHealthtechMedical DevicesIrvine, US

Donald E. Bobo, Jr.(Executive Officer)inScott B. Ullem(Executive Officer)inLarry L. Wood(Executive Officer)inHuimin Wang(Executive Officer)inCatherine M. Szyman(Executive Officer)Bernard Zovighian(Director and Chief Executive Officer)in

Board seatWilliam J. Link· per SEC Form D · $272.4M raise · filed Feb 2017

Co-investorsALIVE Israel HealthTech FundPeregrine Ventures

Lensarlensar.comNASDAQ: LNSRMay 2023SEC filingmedium confidence

Lensar designs and markets laser systems for cataract surgery and corneal astigmatism correction, offering products that incorporate imaging and precision-guidance technologies to help surgeons achieve consistent visual outcomes.

HealthtechOrlando, US

Randy W Frey(Director)Alan B Connaughton(Executive Officer)inAmy R Brooks(Executive Officer)Peter J Mariani(Executive Officer)Keith H Edwards(Executive Officer)Ronald D Goldrich(Executive Officer)

Board seatWilliam J. Link· per SEC Form D · $20M raise · filed May 2023

Co-investorsAisling Capital

Rxsightrxsight.comin𝕏NASDAQ: RXSTFeb 2017SEC filingmedium confidence

RxSight develops the Light Adjustable Lens (LAL), an FDA-approved intraocular lens that surgeons can adjust after cataract surgery to fine-tune a patient's prescription once the eye has healed.

HealthtechMedical DevicesPasadena, US

Robert H. Grubbs(Director)Daniel M. Schwartz(Director)D. Verne Sharma(Executive Officer, Director)Richard Drinkward(Executive Officer)inRon Kurtz(President, Chief Executive Officer & Director)Mark Wilterding(Chief Financial Officer)in

Board seatWilliam Link· per SEC Form D · $77.5M raise · filed Apr 2017

Co-investorsFlying L PartnersForesite CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersLongitude CapitalRA Capital+2 more

Second Sight Medical Productsvivani.comNASDAQ: VANIAug 2018SEC filingmedium confidence

Vivani develops miniaturized, long-acting subdermal drug implants using its NanoPortal technology to deliver steady doses of medication over months, addressing medication adherence challenges in chronic disease.

BiotechHealthtechMedical DevicesSylmar, US

ALFRED MANN(Director)ROBERT GREENBERG(Executive Officer, Director)inEdward Sedo(Acting Chief Accounting Officer)Scott Dunbar(Acting CEO)KATHY LONDON(Executive Officer)Adam Mendelsohn(CEO)

Board seatWilliam Link· per SEC Form D · $5M raise · filed Aug 2018

Co-investorsVersant Side

AcuFocus, Inc.acufocus.comAug 2016SEC filingmedium confidence

BiotechIrvine, US

Alan Waterhouse(President and Chief Operating Officer)Jason Tester(Chief Financial Officer and Secretary)James V. Mazzo(President, Chief Executive Officer and Chairman of the Board)

BoardArjun Arora(Director)Richard L. Lindstrom, M.D.(Director)

Board seatWilliam J. Link· per SEC Form D · $2M raise · filed Aug 2016

Co-investorsEvidity Health CapitalFlying L PartnersRevelation PartnersHEALTHCARE ROYALTY PARTNERSSV Life SciencesVersant Ventures

Allegro OphthalmicsinMay 2017SEC filingmedium confidence

BiotechSan Juan Capistrano, US

Hampar Karageozian(Member of Board of Managers and Chief Executive Officer)inVicken Karageozian(Member of Board of Managers and Chief Technical Officer)inJohn Park(Executive Officer, Director)inMarc D. Kirshbaum(Member of Board of Managers and Chief Operating Officer)in

BoardA. Thomas Bender(Member of Board of Managers)Robert Byrnes(Member of Board of Managers)

Board seatWilliam LinkWilliam J. Link· per SEC Form D · $13.5M raise · filed Jan 2019

Equinox Ophthalmic, Inc.equinoxus.comAug 2019SEC filingmedium confidence

HealthtechSioux Falls, US

TYLER STOWATER(Director)JOHN BERDAHL(Executive Officer, Director)JEFFRY WEINHUFF(Director)

BoardRICHARD LINDSTROM(Director)J. ANDY CORLEY(Director)

Board seatWilliam Link· per SEC Form D · $22M raise · filed Sep 2019

Co-investorsFlying L Partners

Oyster Point Pharma, Inc.oysterpointrx.com𝕏Oct 2017SEC filingmedium confidence

A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments.

BiotechHealthtechSan Francisco, US

Jeffrey Nau(Executive Officer, Director)inMark A. Murray(Executive Officer, Director)D. Michael Ackermann(Director)

BoardAli Behbahani(Director)in

Board seatWilliam J Link· per SEC Form D · $43.1M raise · filed Oct 2017

Co-investorsFlying L PartnersNew Enterprise Associates (NEA)Versant VenturesVida Ventures

TearCleartearclear.cominMay 2017SEC filingmedium confidence

BiotechCopley, US

Kevin Hershfield(Executive Officer, Director)in

BoardJeffry Weinhuff(Director)Tyler Stowater(Director)Richard Heinick(Director)Steve Pazol(Director)

Board seatWilliam Link· per SEC Form D · $4.6M raise · filed May 2017

Co-investorsFlying L PartnersVisionary VenturesVisionary Venture

ViaLasevialase.cominMar 2019SEC filingmedium confidence

ViaLase develops the ViaLase Laser System, a femtosecond laser and HD imaging platform for noninvasive interventional glaucoma treatment that creates apertures through the trabecular meshwork in patients with open-angle glaucoma.

Deep TechHealthtechMedical DevicesAliso Viejo, US

Tibor Juhasz(Executive Officer, Director)inRick Lewis(Executive Officer)Scott Cooper(Executive Officer)Hadi Srass(Executive Officer)inShawn O'Neil(Executive Officer)in

Board seatWilliam Link· per SEC Form D · $8.1M raise · filed Apr 2019

Co-investorsArboretum Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

eyeBrain MedicalOneFocus VisionPrelude CorpSightlife Surgical

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 4

4 IPOs

Edwards LifesciencesNYSE: EWLensarNASDAQ: LNSRRxsightNASDAQ: RXSTSecond Sight Medical ProductsNASDAQ: VANI

Frequently asked questions

How many investments has Versant Venture AIV Holdings made?
Versant Venture AIV Holdings has 14 tracked investments, 4 of which have exited.
Where is Versant Venture AIV Holdings located?
Versant Venture AIV Holdings is headquartered in San Francisco, US.

Featured in lists